Clinical Trial Update: Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma. [Phase 2]

View source ↗

Summary

This document announces a Phase 2 clinical trial evaluating an oxaliplatin-based chemotherapy regimen in patients with resistant or relapsed Non-Hodgkin lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Conditions: Non-Hodgkin Lymphoma | Phase 2 | Status: UNKNOWN